No drug effect, 4 experiments: A wells as n 7.1%; B experiments unpaired (log2) 0.5%; C log2 ratio of % input, paired 5.0%; D log2 ratio of fold over IgG, paired 4.8%
Drug halves binding, 4 experiments: A wells as n 97.6%; B experiments unpaired (log2) 54.0%; C log2 ratio of % input, paired 87.9%; D log2 ratio of fold over IgG, paired 28.2%
Drug halves binding, 6 experiments: A wells as n 99.6%; B experiments unpaired (log2) 83.7%; C log2 ratio of % input, paired 99.5%; D log2 ratio of fold over IgG, paired 51.2%
Drug halves binding, 3 experiments: A wells as n 93.0%; B experiments unpaired (log2) 31.2%; C log2 ratio of % input, paired 58.3%; D log2 ratio of fold over IgG, paired 18.6%